Omicron: The 'noticeable' symptom of the variant appearing in people's hair post-infection

The recent wave of Omicron has racked the UK, but scientists are positive current countermeasures will safeguard the nation. Having worked at full tilt to characterise the variant, researchers have established that a string of symptoms help it stand out from its predecessors. Generally speaking, these include night sweats, a scratchy throat and muscle pain. In the months that follow an infection, however, those infected with Omicron may notice changes in their hair too.

Evidence is growing that Omicron is less likely to cause severe illness, but undesirable side effects may strike further down the line.

Some of the symptoms specific to the variant include a scratchy throat, muscle aches and night sweats.

Conversely, reports of common complications associated with COVID-19, such as loss of smell and taste, have become rare.

But in recent developments, hair loss has now also been linked to Omicron.

 

READ MORE: Should I Try To Get Omicron? No, You Should Not Try to Get Omicron – Here’s Why?

According to the American Academy of Dermatology Association, hair shedding is a common symptom after infection with COVID-19.

It occurs when more hair follicles enter their “shedding” phase post-fever, the complication is believed to be a normal occurrence after fever.

The health body explains: “Fever is a common symptom of COVID-19. A few months after having a high fever or recovering from an illness, many people see noticeable hair loss.

“While many people think of this as hair loss, it’s actually hair shedding.

High temperature has in fact been considered one of the most important symptoms of COVID-19 since its emergence.

It is also one of the symptoms that distinguish the virus from the common cold, alongside chills, and a headache.

Thankfully, the World Health Organisation is seeing growing evidence that the symptoms of Omicron are milder than the previous variant.

But studies to date have shown that each infection with the strain produces at least three more – a trend comparable to the first wave of the pandemic.

Hopes of flattening the curve on the infection now hinge on whether the vaccine is able to withstand the 35 mutations in the strain’s spike protein.

Generally speaking, those who have completed a course of COVID-19 vaccines are protected from symptomatic infection with the strain.

It comes as the Prime Minister announced earlier this week that skipping “balanced measures” would help outpace rising cases of Omicron.

Boris Johnson told the Commons: “So in response to the latest data, the Cabinet agreed this morning that we should stick with Plan B for another three weeks, with a further review before the regulations expire on 26 January.”

Source: | This article first appeared on Express.co.uk

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

What To Do If You Test Positive For COVID-19 While Traveling – Reliable Tips

What To Do If You Test Positive For COVID-19 While Traveling –…

Merck to make its COVID-19 antiviral pill in Canada, company announces

Merck has reached an agreement with an Ontario pharmaceutical to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.

What to Know About the U.S. Summer Uptick in Covid-19 Cases

What to Know About the U.S. Summer Uptick in Covid-19 Cases –…

Germany to pass 100,000 deaths from COVID-19 as virus surges again

Germany is poised to pass the mark of 100,000 deaths from COVID-19 this week, a somber milestone that several of its neighbors crossed months ago but which Western Europe’s most populous nation had hoped to avoid. Discipline, a robust health care system and the rollout of multiple vaccines — one of them homegrown — were…